S&P 500 Futures
(0.28%) 5 169.25 points
Dow Jones Futures
(0.24%) 38 927 points
Nasdaq Futures
(0.26%) 18 048 points
Oil
(1.05%) $78.93
Gas
(0.47%) $2.15
Gold
(0.96%) $2 330.70
Silver
(2.63%) $27.39
Platinum
(1.12%) $976.10
USD/EUR
(-0.04%) $0.928
USD/NOK
(-0.19%) $10.85
USD/GBP
(-0.22%) $0.795
USD/RUB
(0.06%) $91.50

Actualizaciones en tiempo real para Hyundai Pharmaceutical [004310.KS]

Bolsa: KSC Sector: Healthcare Industria: Drug Manufacturers—Specialty & Generic
Última actualización3 may 2024 @ 02:30

-0.26% KRW 3 785.00

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally...

Stats
Volumen de hoy 28 167.00
Volumen promedio 61 776.00
Capitalización de mercado 105.52B
EPS KRW65.00 ( 2023-08-31 )
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW2.27 (0.06%)

Volumen Correlación

Largo: -0.17 (neutral)
Corto: -0.82 (strong negative)
Signal:(57.535) Neutral

Hyundai Pharmaceutical Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hyundai Pharmaceutical Correlación - Moneda/Commodity

The country flag -0.05
( neutral )
The country flag -0.15
( neutral )
The country flag 0.22
( neutral )
The country flag 0.11
( neutral )
The country flag -0.40
( neutral )
The country flag -0.30
( neutral )

Hyundai Pharmaceutical Finanzas

Annual 2023
Ingresos: KRW180.76B
Beneficio Bruto: KRW76.59B (42.37 %)
EPS: KRW225.81
FY 2023
Ingresos: KRW180.76B
Beneficio Bruto: KRW76.59B (42.37 %)
EPS: KRW225.81
FY 2022
Ingresos: KRW162.69B
Beneficio Bruto: KRW68.84B (42.31 %)
EPS: KRW-5.92
FY 2021
Ingresos: KRW139.80B
Beneficio Bruto: KRW56.31B (40.28 %)
EPS: KRW-115.95

Financial Reports:

No articles found.

Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and eye vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. The company was founded in 1965 and is headquartered in Seoul, South Korea.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico